Terminalia elliptica
Terminalia elliptica
Terminalia elliptica is a tree native to various forest ranges in several regions. While traditional uses for this plant are not well-documented, studies have shown that its phytobioactives exhibit notable binding affinity with FAK, VEGF, and MTA1 proteins, suggesting potential biological activity. Research also indicates significant variations in the diversity, density, and biomass accumulation of T. elliptica across different forest ranges, with higher recruitment observed in sacred groves compared to human settlements. The carbonization process at 400 °C yielded activated carbons with superior electrochemical performance, and their MnO2 composite further enhanced specific capacitance and energy density, though these findings are currently limited to non-biological applications. No major safety issues or drug interactions have been recorded for this plant.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- The study found that phytobioactives from Terminalia elliptica showed notable binding affinity with FAK, VEGF, and MTA1 proteins.
- A total of 80 tree species were recorded across five forest ranges, with significant variations in diversity, density, and biomass accumulation.
- Giant Terminalia elliptica trees were more common and taller in sacred groves than in human settlements, supporting higher sapling recruitment.
- The study found that carbonizing at 400 °C yielded activated carbons with superior electrochemical performance, and their MnO2 composite further enhanced specific capacitance and energy density.
Frequently asked questions
What is Terminalia elliptica?
Terminalia elliptica (Terminalia elliptica) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Terminalia elliptica?
4 sourced findings are recorded for Terminalia elliptica; the strongest carries evidence grade D. For example: The study found that phytobioactives from Terminalia elliptica showed notable binding affinity with FAK, VEGF, and MTA1 proteins.
How strong is the evidence for Terminalia elliptica?
The strongest finding for Terminalia elliptica carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Terminalia elliptica safe? What are the side effects?
No major safety issues are recorded for Terminalia elliptica in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Terminalia elliptica interact with medications?
No drug interactions are recorded for Terminalia elliptica in our sources. This does not rule them out — check with a pharmacist.
Is Terminalia elliptica a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Structural and electrochemical evaluation of renewable carbons and their composites on different carbonization temperatures for supercapacitor applications. literature abstract metadata
- T2 Targeting FAK, VEGF, and MTA1 proteins with Terminalia elliptica: a computational approach for anticancer activity. literature abstract metadata
- T2 Tree diversity, population structure, biomass accumulation, and carbon stock dynamics in tropical dry deciduous forests of Eastern India. literature abstract metadata
- T2 Giant trees enhance zoochorous plant dispersal in sacred groves and human settlements of the Western Ghats, India. literature abstract metadata